Galectin Therapeutics Inc
GALT· Nasdaq
GALTGalectin Therapeutics Inc
Filed Mar 18, 2015 · 10-K · 77 days after period end · 0001193125-15-096928
| Metric | Q4 2014 | Q4 2013 | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$3.73M | -$2.80M | -$2.38M | -$3.37M |
| EPS Diluted | -$0.17 | -$0.14 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 18, 2015 · 77 d after period end
